Similar articles

• [Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].

  Powłowska I, Rakowska Z. Powłowska I, et al. Pneumonol Pol. 1978 Aug;46(8):605-12. Pneumonol Pol. 1978. PMID: 714703 Polish. No abstract available.
• [Clinical pharmacology of isoniazid].

  Sokolova GV, Ivleva AIa, Ziia AV, Zeliger LR, Suvorova VI. Sokolova GV, et al. Probl Tuberk. 1984 Sep;(9):55-60. Probl Tuberk. 1984. PMID: 6504886 Russian. No abstract available.
• Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations.

  Smirnov GA. Smirnov GA. Fed Proc Transl Suppl. 1966 Jan-Feb;25(1):72-6. Fed Proc Transl Suppl. 1966. PMID: 5322111 Clinical Trial. No abstract available.
• The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.

  Ellard GA. Ellard GA. Tubercle. 1984 Sep;65(3):211-27. doi: 10.1016/0041-3879(84)90079-5. Tubercle. 1984. PMID: 6385429 Review. No abstract available.
• Genetic factors in drug therapy.

  Evans DA. Evans DA. Sci Basis Med Annu Rev. 1969:166-82. Sci Basis Med Annu Rev. 1969. PMID: 4918368 Review. No abstract available.